Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xeris Biopharma Holdings (XERS) Tax Rate: 2022-2024

Historic Tax Rate for Xeris Biopharma Holdings (XERS) over the last 2 years, with Sep 2024 value amounting to 17.44%.

  • Xeris Biopharma Holdings' Tax Rate rose 1474.00% to 17.44% in Q3 2024 from the same period last year, while for Sep 2024 it was 3.82%, marking a year-over-year increase of 114.00%. This contributed to the annual value of 3.97% for FY2024, which is 200.00% up from last year.
  • Latest data reveals that Xeris Biopharma Holdings reported Tax Rate of 17.44% as of Q3 2024, which was up 906.81% from 1.73% recorded in Q4 2023.
  • In the past 5 years, Xeris Biopharma Holdings' Tax Rate registered a high of 17.44% during Q3 2024, and its lowest value of 1.20% during Q1 2022.
  • Moreover, its 3-year median value for Tax Rate was 2.14% (2023), whereas its average is 3.96%.
  • In the last 5 years, Xeris Biopharma Holdings' Tax Rate tumbled by 82bps in 2023 and then soared by 1,474bps in 2024.
  • Quarterly analysis of 3 years shows Xeris Biopharma Holdings' Tax Rate stood at 2.55% in 2022, then plummeted by 82bps to 1.73% in 2023, then spiked by 1,474bps to 17.44% in 2024.
  • Its Tax Rate stands at 17.44% for Q3 2024, versus 1.73% for Q4 2023 and 2.70% for Q3 2023.